HWAM
AXSM icon

Hennion & Walsh Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Hennion & Walsh Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Sell
17,505
-19,128
-52% -$4.15M 0.12% 218
2026
Q1 		$6.19M Sell
36,633
-1,753
-5% -$303K 0.21% 106
2025
Q4 		$7.01M Sell
38,386
-8,530
-18% -$1.19M 0.24% 84
2025
Q3 		$5.7M Sell
46,916
-2,984
-6% -$336K 0.21% 115
2025
Q2 		$5.21M Sell
49,900
-9,373
-16% -$992K 0.21% 105
2025
Q1 		$6.91M Buy
59,273
+1,437
+2% +$164K 0.31% 58
2024
Q4 		$4.89M Sell
57,836
-312
-0.5% -$28.7K 0.22% 98
2024
Q3 		$5.23M Sell
58,148
-6,537
-10% -$571K 0.24% 93
2024
Q2 		$5.21M Sell
64,685
-4,798
-7% -$355K 0.27% 78
2024
Q1 		$5.54M Buy
69,483
+8,867
+15% +$744K 0.3% 64
2023
Q4 		$4.82M Sell
60,616
-6,430
-10% -$430K 0.28% 75
2023
Q3 		$4.69M Sell
67,046
-10,391
-13% -$777K 0.3% 71
2023
Q2 		$5.57M Sell
77,437
-16,827
-18% -$1.24M 0.33% 65
2023
Q1 		$5.81M Buy
94,264
+1,074
+1% +$70.6K 0.36% 64
2022
Q4 		$7.19M Sell
93,190
-13,392
-13% -$800K 0.44% 48
2022
Q3 		$4.76M Buy
106,582
+8,092
+8% +$404K 0.31% 72
2022
Q2 		$3.77M Sell
98,490
-6,647
-6% -$210K 0.23% 115
2022
Q1 		$4.35M Buy
105,137
+10,090
+11% +$313K 0.23% 116
2021
Q4 		$3.59M Buy
95,047
+14,836
+18% +$546K 0.18% 162
2021
Q3 		$2.64M Buy
80,211
+3,984
+5% +$155K 0.14% 208
2021
Q2 		$5.14M Buy
76,227
+18,054
+31% +$1.08M 0.27% 86
2021
Q1 		$3.29M Buy
+58,173
New +$4.09M 0.2% 139

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
CA
Cannon Advisors Charlotte, North Carolina $164M AUM 30.34% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Hennion & Walsh Asset Management's AXSM Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Axsome Therapeutics (AXSM) stake by 52% in Q2 2026, selling an estimated $4.15M and leaving 17,505 shares worth $4.28M. The position accounts for 0.12% of the portfolio, ranked #218.

Hennion & Walsh Asset Management first reported a position in AXSM in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.19M in Q4 2022. 38 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Hennion & Walsh Asset Management held 17,505 shares of Axsome Therapeutics worth $4.28M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 19,128 Axsome Therapeutics shares in Q2 2026, an estimated $4.15M.
  • Axsome Therapeutics made up 0.12% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #218 holding.
  • Hennion & Walsh Asset Management first reported a position in Axsome Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Hennion & Walsh Asset Management's Axsome Therapeutics position peaked at $7.19M in Q4 2022.
  • 38 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.